Workflow
生物基材料
icon
Search documents
凯赛生物:在生物基复合材料的联合开发与应用方面,公司正与招商局集团旗下相关单位紧密协作
Zheng Quan Ri Bao Wang· 2026-01-22 12:13
Core Viewpoint - Kaisa Bio is actively collaborating with relevant units under China Merchants Group for the joint development and application of bio-based composite materials, focusing on multiple potential application scenarios such as containers and construction templates [1] Group 1 - The company is conducting continuous product testing, process optimization, and performance validation work in collaboration with its partner [1] - Efficient and pragmatic communication is maintained between the teams to address key issues in the product development process [1] - Some products have already been delivered in small batch orders [1]
凯赛生物:在生物基复合材料领域的各项合作与市场拓展工作均在稳步推进中
Zheng Quan Ri Bao Wang· 2026-01-22 11:41
Core Viewpoint - The company is making steady progress in its collaborations and market expansion in the field of bio-based composite materials [1] Group 1: Collaborations and Market Development - The company is actively communicating with relevant partners regarding building templates [1] - The focus is on addressing various specific issues in the industrialization process [1] - The goal is to provide the market with mature, reliable, and competitive solutions [1]
签约!糖能科技×江南大学强强联合,解锁生物基材料食品应用新赛道!
synbio新材料· 2026-01-22 03:40
Group 1 - The core viewpoint of the article highlights the collaboration between Zhejiang Sugar Energy Technology Co., Ltd. and Jiangnan University to establish a joint innovation center focused on biobased materials in the food application sector [1][3] - The joint innovation center aims to develop and transform green antibacterial products and functional health foods, centering on food-grade 5-hydroxymethylfurfural (5-HMF) [3] - The center will operate under a "dual-base, co-management" model, ensuring seamless integration of research and industrialization, with Sugar Energy providing funding and high-quality raw materials while Jiangnan University manages technical research and daily operations [3] Group 2 - The construction of Sugar Energy's 10,000-ton 5-HMF production project is set to be completed by December 29, 2025, with production expected to start in June 2026 [4] - The chairman of Sugar Energy stated that this project represents a significant leap towards the industrialization of the company's core technological achievements and aligns with the national "dual carbon" strategy [4] - Founded in 2017, Zhejiang Sugar Energy Technology Co., Ltd. is a national high-tech enterprise focused on the design, development, production, and application promotion of biobased new materials, particularly 5-HMF and its derivatives [4]
今晚20:00直播!《高性能呋喃生物基材料PEF的研发和产业化》
synbio新材料· 2026-01-22 03:40
生物基材料作为替代传统石油基制品的关键方向,正迎来重要发展机遇。其中, 呋喃生物基材料 PEF 凭借高阻隔性、全生命周期低碳等优势,被视为下一代 聚酯材料的核心代表。 利夫生物 作为国内 FDCA 与 PEF 产业化领军企业,已先后建成百吨级、千吨级产线,其 万吨级生产线正在建设中 。 此外,利夫生物还 开拓了生物基芳香 族材料在食品饮料、纺织服装、3C汽车等领域的应用 ,与众多全球龙头企业建立了战略合作伙伴关系。 3)在包装领域,PEF具备数倍于传统食品接触材料的阻隔性,是理想的敏感性内容物包装材料,目前正在饮料、啤酒、果汁等场景广泛落地。 4)在纺织服装领域,利夫生物所创立的BioFleax™(PEF纤维),具备优异的吸湿速干性能、天然抑菌防螨性能、本征防晒性能,目前正被众多国际一线 品牌用于高性能服装开发。 为此,synbio深波有幸邀请到了 利夫生物CMO罗钊先生于 1月22日晚上20:00 在【synbio深波视频号】进行直播分享 , 直播 分享主题: 《 高性能呋喃生物 基材料PEF的研发和产业化 》 。 点击下方,立即 预约直播 ! (*预约后直播开始时微信会自动提醒) 锁定1月22日晚20:0 ...
中科院化学所孵化,产品已导入头部3C供应链,纤维素高值应用平台「格林微纳」完成数千万元Pre-A轮融资|36氪首发
3 6 Ke· 2026-01-22 02:53
36氪获悉,纤维素高值应用平台「格林微纳」近期宣布完成数千万元Pre-A轮融资。本轮融资由金桥基金领投,产业方跟投,义柏资本担任财务顾问,资 金将主要用于生产线扩建及市场推广。 文 | 阿至 格林微纳成立于2022年10月,核心技术孵化自中国科学院化学研究所,技术带头人张军为中科院化学所工程塑料实验室主任、研究员、博士生导师,是天 然高分子及纤维素材料研究领域著名科学家,其带领的科研团队拥有20年基础研究积累,10余年产业化实践经验。公司核心团队来自于中科院化学所、丹 纳赫、中科恒联等,具备从研发、生产到商业化运营的综合能力。 格林微纳核心技术为微纳米纤维素功能材料的制备,通过全新的离子液体绿色加工技术路线,重塑纤维素物理形态与化学功能,如3D纤维素凝胶 (CMG)、微球/微胶囊等,从而实现功能型产品的创新和多领域应用。 目前,格林微纳重点发力纸制品、日化个护、工业助剂和生命科学四大业务领域,依托现阶段核心材料3D纤维素凝胶、微球/微胶囊的独特形态及性能, 对应布局8大产品管线,例如纸品增强剂、天然护肤品多效添加剂等。 企业供图 过去一年,在纸品和日化领域,格林微纳已与多家消费电子供应链企业、国际护肤品牌OD ...
DT新叶奖竞选⑩ | 华澄生物:生物基蓝色素、印染绿色解决方案
Core Viewpoint - The article highlights the participation of Jiangsu Huacheng Biotechnology Co., Ltd. in the 2026 DT New Leaf Award, focusing on its innovative bio-based blue pigment and green dyeing solutions aimed at promoting sustainable practices in the textile industry [2][13]. Group 1: Company Overview - Jiangsu Huacheng Biotechnology Co., Ltd. was established in 2024, focusing on synthetic biology research and product commercialization, particularly in bio-based materials and biochemicals for pharmaceuticals, cosmetics, food, and health products [3]. - The company aims to drive industrial upgrades through technological innovation, emphasizing large-scale bio-manufacturing of food colorants, chemical dyes, and functional food ingredients [3]. Group 2: Bio-based Blue Pigment - The bio-based blue pigment is produced using synthetic biology techniques, utilizing engineered microorganisms as "cell factories" for efficient fermentation [4]. - Compared to chemical dyes, bio-based dyes are natural, non-toxic, and exhibit excellent antibacterial and anti-yellowing properties, with lower damage to high-end fabrics like silk and wool [4][10]. - The production process avoids traditional petroleum-based methods, reducing harmful substance generation and wastewater treatment costs, while achieving USDA bio-based product certification [8][10]. Group 3: Green Dyeing Solutions - Traditional chemical dyes pose significant health and environmental risks, leading to complex pollution issues in the textile industry [9]. - Huacheng's approach involves replacing chemical dyes with bio-based alternatives, providing scalable clean dyeing solutions that align with national environmental goals [9]. - The innovative process utilizes renewable carbon sources and mild fermentation conditions, significantly lowering wastewater chemical oxygen demand and overall energy consumption [9]. Group 4: Awards and Recognition - The DT New Leaf Award features four categories: Innovation Material Award, Innovation Application Award, Most Commercially Valuable Award, and Innovative Industry Solution Award, with the first round of applications closing on February 10, 2026 [5][13]. - Huacheng's participation in the award reflects its commitment to sustainable practices and innovation in the bio-based industry [2][13].
DT新叶奖第①批公示: 万华化学/利夫生物/骐业科技/聚维元创/华呋新材/浩森生物等亮相(持续更新)
Core Viewpoint - The "2026 DT New Leaf Award" is a global and comprehensive award focused on innovation in the bio-based sector, aimed at discovering, showcasing, and recognizing outstanding products and companies in the bio-based industry [2]. Group 1: Award Overview - The award symbolizes vitality and sustainable innovation, with the goal of uncovering pioneering forces in the bio-based industry that utilize renewable biomass and green technologies to drive low-carbon development [2]. - Over 30 representative companies from the bio-based industry are participating in the "2026 DT New Leaf Award" evaluation, with the first batch of participating companies announced [2]. Group 2: Participating Companies and Products - Wanhua Chemical Group Co., Ltd. is recognized as a leading global chemical new materials enterprise, participating with its low-carbon PCDL product, which is a versatile polyol used for high-end polyurethane materials [3]. - Leaf Bio, a global leader in bio-based aromatic materials, focuses on the development and production of furan-based materials, with core products FDCA and PEF being recognized as potential bio-based platform compounds [4]. - Henan Qiye Technology Development Co., Ltd. is the world's first company to produce non-food cellulose crystalline glucose in bulk, showcasing its innovative production techniques [5]. - Suzhou Polywin Biotechnology Co., Ltd. specializes in straw-based bio-manufacturing, presenting products such as bio-based 1,4-butanediamine and fully bio-based packaging materials [8]. - Ningbo Huafu New Materials Technology Co., Ltd. has developed a novel air oxidation route for producing FDCA, significantly reducing production costs and enhancing competitiveness [11][12]. - Henan Haosen Biological Materials Co., Ltd. has pioneered a continuous production process for bio-based 1,5-pentanediol using non-food biomass, achieving large-scale and efficient green production [15]. Group 3: Award Categories and Timeline - The award features four main categories: Innovation Material Award, Innovation Application Award, Most Commercially Valuable Award, and Innovative Industry Solution Award, likened to the "Oscars" of the bio-based industry [19]. - The first round of applications is open until February 10, 2026, with subsequent voting and evaluation phases scheduled for March 2026, culminating in an award ceremony on May 21, 2026 [27].
赢创/Avantium/苏尔寿/利夫都来了!第11届生物基展览已订50+赞助商
Core Viewpoint - The 11th Bio-based Conference and Exhibition will be held from May 20-22, 2026, in Shanghai, China, focusing on the latest achievements in the bio-based industry and the demands from the application side [1][17]. Group 1: Event Overview - The theme of the event is "Crossing New Cycles, Surging New Vitality," featuring 11 thematic forums, 7 concurrent activities, 1000 new product displays, and an innovation award ceremony [2][10]. - Over 50 sponsors have already confirmed their participation, including leading companies in the bio-based sector such as Evonik, Avantium, and others [2][3]. Group 2: Focus Areas - The exhibition will emphasize bio-based innovative materials and products in packaging, textiles, automotive, 3D printing, coatings, adhesives, and more [3][6]. - It aims to connect the supply and demand sides of the bio-based industry, focusing on the needs of downstream brand owners and facilitating strategic cooperation and procurement [6][7]. Group 3: Thematic Forums and Activities - The event will host 11 thematic forums covering key topics such as critical chemicals and materials, international cooperation, and bio-based applications in various industries [17][18]. - Seven concurrent activities will include a new product and technology release conference, a standard review meeting, and a high-level strategic seminar [18]. Group 4: Innovation and Awards - The 4th DT New Leaf Award will be held concurrently, recognizing innovations in materials, applications, commercial value, and industry solutions [19].
又一聚乳酸材料企业完成近亿元融资
Sou Hu Cai Jing· 2026-01-13 16:48
Core Insights - Shanghai Jinghai Weixiang Biotech Co., Ltd. has successfully completed nearly 100 million RMB in Series B financing, exclusively funded by Jiazhi Fund, and is preparing for Series B+ financing [1] - The company focuses on "AI + synthetic biology + bio-based materials" and has established a closed-loop innovation model since its inception in 2020, creating a full industry chain layout from non-food biomass to product recycling [1][3] Company Overview - Jinghai Weixiang is recognized as a national high-tech enterprise and a specialized and innovative enterprise in Shanghai, emphasizing green and low-carbon production through advanced biomanufacturing technologies [1] - The company has developed several internationally leading production technologies for bio-based materials, including breakthroughs in non-food biomass utilization and new generation industrial strains [3] Technology and Products - Key technologies include gypsum-free lactic acid production, which addresses environmental pollution from traditional methods, and rPLA recycling, which enables the closed-loop lifecycle of polylactic acid (PLA) products [3] - PLA, the company's core product, is a high-performance biodegradable material with applications across various sectors, including fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [3] Financing and Growth Plans - The funds from the recent financing round will be primarily used for expanding the production capacity of the company's scale-up base, developing next-generation technologies, and expanding market channels [4] - The company has achieved significant milestones in the industrialization of bio-based materials, with steady increases in production capacity and market share, and this financing will accelerate its growth and solidify its industry-leading position [4]
又一聚乳酸材料企业完成近亿元融资
DT新材料· 2026-01-13 16:05
Core Viewpoint - The article highlights the successful completion of nearly 100 million RMB in Series B financing by Jinghai Weixiang, a company focused on "AI + synthetic biology + bio-based materials," aiming to establish a green and low-carbon production system in the bio-based materials industry [2][5]. Company Overview - Jinghai Weixiang, established in 2020, is recognized as a national high-tech enterprise and a specialized and innovative enterprise in Shanghai, focusing on a closed-loop innovation model in bio-based materials [2]. - The company has developed a comprehensive industrial chain from non-food biomass to lactic acid, polylactic acid (PLA), products, and rPLA recycling, positioning itself as a benchmark for green transformation and high-quality development in the industry [2][4]. Technological Advancements - The company has achieved several international-leading technologies in the bio-based materials production chain, including breakthroughs in non-food biomass utilization, new-generation industrial strains, gypsum-free lactic acid technology, and rPLA recycling [4]. - The gypsum-free lactic acid technology addresses environmental pollution issues associated with traditional lactic acid production, enabling cleaner and lower-cost production [4]. - The rPLA recycling process allows for the same-level recycling of PLA, effectively reducing production costs and creating a closed-loop lifecycle for PLA products [4]. Product Applications - PLA, the core product of Jinghai Weixiang, is a high-performance biodegradable material with excellent biocompatibility, degradability, and processing capabilities, widely used in various sectors including fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [4]. - The company's integrated production system ensures stable product quality and significant cost advantages, providing comprehensive solutions for bio-based materials [4]. Financing and Growth Strategy - The recent financing will primarily support the expansion of Jinghai Weixiang's large-scale production base, the iterative development of new technologies, and the expansion of market channels [5]. - The company has made significant progress in the industrialization of bio-based materials, with steady increases in production capacity and market share, and this financing will accelerate its growth and solidify its leading position in the industry [5].